spacer
home > ebr > spring 2019 > the road to success
PUBLICATIONS
European Biopharmaceutical Review

The Road to Success

When thinking of biomarkers and their role in delivering personalised medicine, most will picture recent advances in oncology and, in particular, those that have arisen following seminal developments in human genomics, including the publishing of the human genome sequence in 1999. However, in reality, biomarkers have been around for much longer and have been driving a move to a more personalised approach to medicine for many years. This article examines both historical and modern groundbreaking examples to explain and exemplify the different types of biomarkers and their use in medicine.

Defining Biomarkers

There are many definitions of biomarkers, but this article will focus on one from a WHO collaborative study which defined a biomarker as “any substance, structure, or process that can be measured in the body or its products and influence or predict the incidence of outcome or disease” (1). If this definition is extended to include the effects of treatments, interventions, and exposure to environmental agents such as chemicals or nutrients, the possibilities are endless.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karen Hills is Director of Marketing and Medical Affairs at PredictImmune, focussing on the launch of new products and clinical studies. Her background includes medical and marketing roles in both startup companies and Big Pharma. Karen has a PhD from the University of Cambridge and an Executive MBA from London Business School, UK.

Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge and is Chief Medical Officer at PredictImmune. He trained in nephrology and clinical immunology and completed a PhD at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. His lab runs a translational programme in autoimmune disease (particularly IBD, vasculitis, and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
spacer
Dr Karen Hills
spacer
spacer
spacer
Professor Ken Smith
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement